Definitive Healthcare Corp [DH] stock prices are up 3.48% to $9.52 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DH shares have gain 2.92% over the last week, with a monthly amount glided 5.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023. In a post published today on Yahoo Finance, Fourth quarter revenue grew 9% year-over-year to $65.9 million.
From an analyst’s perspective:
Definitive Healthcare Corp [NASDAQ: DH] stock has seen the most recent analyst activity on January 17, 2024, when Needham downgraded its rating to a Hold. Previously, Canaccord Genuity downgraded its rating to Hold on January 05, 2024. On July 24, 2023, downgrade downgraded it’s rating to Neutral but maintained its price target of $13 on the stock. William Blair started tracking the stock assigning a Outperform rating. BofA Securities initiated its recommendation with a Neutral and recommended $13 as its price target on December 09, 2022. Needham started tracking with a Buy rating for this stock on July 06, 2022, and assigned it a price target of $30.
The stock price of Definitive Healthcare Corp [DH] has been fluctuating between $5.53 and $12.45 over the past year. Currently, Wall Street analysts expect the stock to reach $23.67 within the next 12 months. Definitive Healthcare Corp [NASDAQ: DH] shares were valued at $9.52 at the most recent close of the market. An investor can expect a potential return of 148.63% based on the average DH price forecast.
Analyzing the DH fundamentals
The Definitive Healthcare Corp [NASDAQ:DH] reported sales of 246.08M for trailing twelve months, representing a surge of 13.84%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -1.31%, Pretax Profit Margin comes in at -1.22%, and Net Profit Margin reading is -0.82%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.2 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.90 points at the first support level, and at 8.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.38, and for the 2nd resistance point, it is at 11.24.
Definitive Healthcare Corp [DH] reported earnings per share of $0.09 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.06/share, meaning a difference of $0.03 and a surprise factor of 50.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were $0.08 per share as compared to estimates of $0.05 per share, a difference of $0.03 representing a surprise of 60.00%.
Ratios To Look Out For
It’s worth pointing out that Definitive Healthcare Corp [NASDAQ:DH]’s Current Ratio is 2.47. In addition, the Quick Ratio stands at 2.47 and the Cash Ratio stands at 0.77. Considering the valuation of this stock, the price to sales ratio is 4.50, the price to book ratio is 1.28.
Transactions by insiders
Recent insider trading involved SEA VII Management, LLC, Director, that happened on Aug 24 when 6656.0 shares were sold. Director, SEA VII Management, LLC completed a deal on May 12 to sell 6240.0 shares.
